INSPIRE NEWS
Inspire Newsroom
Inspire and Takeda Researchers to Present Novel Study on Short Bowel Syndrome Patient Experience at DDW2024
Inspire has announced that it will present new research at Digestive Disease Week (DDW) 2024, unveiling insights from a mixed-method study on Short Bowel Syndrome (SBS) patient experience.
Inspire study to be presented at ISPOR 2024 reveals insights into chronic lymphocytic leukemia management
At ISPOR 2024, Inspire researchers will present groundbreaking findings in chronic lymphocytic leukemia (CLL) management. By integrating patient voices from Inspire’s community with medical data, the study highlights key unmet needs and long-term complications in CLL care, showcasing the value of real-world patient-centered insights.
New Inspire study with Takeda Pharmaceuticals sheds light on rare neuromuscular diseases
A new Inspire study presented at IgNS 2023 sheds light on the challenges faced by patients with Multifocal Motor Neuropathy (MMN) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). In collaboration with Takeda Pharmaceuticals and leading experts, the study explores the patient journey, highlighting diagnostic challenges, treatment barriers, and unmet needs in education and care.
Inspire hires seasoned leaders Laurel Netolicky and Michael Butterfield in key business development roles
Inspire welcomes Laurel Netolicky and Michael Butterfield as Vice Presidents of Business Development. With extensive experience in digital marketing, advertising, and ad tech sales, both leaders bring expertise that will enhance Inspire’s client offerings, expand market reach, and drive growth while keeping patients at the center of healthcare innovation.
Inspire to host industry webinar on real-world evidence in rare disease on October 12
Join Inspire’s webinar, Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases, on October 12 at 11 a.m. ET. Hosted by Richard Tsai, MS, Senior VP of Real-World Evidence, the event features Takeda experts Megan Gower, PharmD, and Edward Chou, PhD. Explore challenges and strategies for leveraging patient-centered RWE to enhance drug development and rare disease research.
New Inspire study sheds light on short bowel syndrome through real-world data
Inspire’s latest study, presented at ICPE 2023, sheds light on the diagnostic journeys, treatment patterns, and healthcare utilization of short bowel syndrome (SBS) patients. By linking patient data with HIPAA-compliant medical and pharmacy claims, the study reveals prolonged reliance on parenteral nutrition and significant out-of-pocket costs. Insights from Inspire’s online community further emphasize the financial and quality-of-life impacts of SBS, providing valuable context for understanding patient needs and advancing care solutions.